XML 12 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Jan. 28, 2024
Jan. 29, 2023
Cash flows from operating activities:    
Net loss $ (8,954) $ (26,839)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation 4,897 5,228
Non-cash inventory (credit) charge (1,978) 6,301
Amortization 291 323
Stock-based compensation 747 887
Deferred income taxes 172 150
Gain on sale of equipment (284) (312)
Non-cash restructuring expenses 330 791
Foreign currency exchange gain (347) (362)
Changes in assets and liabilities:    
Accounts receivable 1,040 954
Inventories   12,477
Other current assets (1,190) (39)
Other assets (107) (76)
Accounts payable – trade 963 3,051
Deferred revenue 606 910
Accrued expenses and deferred compensation (1,437) 885
Income taxes (719) 254
Net cash (used in) provided by operating activities (5,970) 4,583
Cash flows from investing activities:    
Capital expenditures (3,249) (1,602)
Proceeds from the sale of equipment 363 465
Proceeds from note receivable 240  
Proceeds from the sale of investments (rabbi trust) 1,224 70
Purchase of investments (rabbi trust) (704) (870)
Net cash used in investing activities (2,126) (1,937)
Cash flows from financing activities:    
Common stock surrendered for withholding taxes payable (146) (33)
Payments of debt issuance costs   (289)
Net cash used in financing activities (146) (322)
Effect of exchange rate changes on cash and cash equivalents (137) (149)
(Decrease) increase in cash and cash equivalents (8,379) 2,175
Cash and cash equivalents at beginning of period 20,964 14,550
Cash and cash equivalents at end of period $ 12,585 $ 16,725